161 related articles for article (PubMed ID: 2407166)
1. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
Allison JE; Feldman R; Tekawa IS
Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
[TBL] [Abstract][Full Text] [Related]
2. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity, specificity, and predictive value of fecal occult blood testing (Hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study with total colonoscopy.
Niv Y; Sperber AD
Am J Gastroenterol; 1995 Nov; 90(11):1974-7. PubMed ID: 7485003
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
[TBL] [Abstract][Full Text] [Related]
5. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
6. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
[TBL] [Abstract][Full Text] [Related]
7. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
Petrelli N; Michalek AM; Freedman A; Baroni M; Mink I; Rodriguez-Bigas M
Surg Oncol; 1994 Feb; 3(1):27-36. PubMed ID: 8186868
[TBL] [Abstract][Full Text] [Related]
9. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study.
Rasmussen M; Kronborg O; Fenger C; Jørgensen OD
Scand J Gastroenterol; 1999 Jan; 34(1):73-8. PubMed ID: 10048736
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
11. Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.
Foliente RL; Wise GR; Collen MJ; Abdulian JD; Chen YK
Am J Gastroenterol; 1995 Dec; 90(12):2160-3. PubMed ID: 8540507
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia.
Hope RL; Chu G; Hope AH; Newcombe RG; Gillespie PE; Williams SJ
Gut; 1996 Nov; 39(5):722-5. PubMed ID: 9014773
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated.
Gopalswamy N; Stelling HP; Markert RJ; Maimon HN; Wahlen SD; Haddy RI
Arch Fam Med; 1994 Dec; 3(12):1043-8. PubMed ID: 7804488
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new occult blood tests for detection of colorectal neoplasia.
St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
[TBL] [Abstract][Full Text] [Related]
17. [The Hemoccult II test: results of 16 years of screening tests at the Tumor Prevention Service of the City of Paris].
Souques M; Zummer K
Presse Med; 2000 May; 29(18):983-6. PubMed ID: 10862245
[TBL] [Abstract][Full Text] [Related]
18. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
[TBL] [Abstract][Full Text] [Related]
19. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
